Maccura Biotechnology Co.,Ltd. (300463.SZ) has announced that the company recently received three Medical Device Registration Certificates issued by the Sichuan Provincial Medical Products Administration.

The three certificates cover the Total Type I Collagen Amino-Terminal Propeptide Assay Kit (direct chemiluminescence method), the Beta-CrossLaps Assay Kit (direct chemiluminescence method), and the Osteocalcin Assay Kit (direct chemiluminescence method).

All three products are new reagent products on the company's direct chemiluminescence platform and are primarily used for the auxiliary diagnosis of osteoporosis.

As of now, the company has cumulatively obtained 145 reagent product registration certificates under its direct chemiluminescence platform.